Xaar stock boosted by confidence in upbeat strategy
Cambridge coding and marking technology specialist Xaar plc gave shareholders a welcome boost as its interim results to June 30 painted a brighter picture of the future and predicted a return to...
View ArticleElectric Vehicle movement on the charge!
It could be easy to forget about positive developments taking place, particularly in relation to the built environment and how we go about our lives, writes Greg Hilton, a Partner in Carter Jonas’s...
View ArticleGlorious results for Cambridge cluster law firms in new Legal 500 guide
Cambridge Cluster and East Anglian law firms cover themselves in glory in the new edition of the profession’s ‘bible’ – The Legal 500 clients guide –published online today by Legalease.Particularly...
View ArticleArm-fired Bamboo shoots for hi-tech heavens with $7m funding
Cambridge Science Park server architecture specialist Bamboo Systems has closed a $7 million funding round to take its Arm-based technology proposition to greater global heights in an $80 billion...
View ArticleCambridge company acquired by NASDAQ IT giant
NASDAQ-listed Altair has acquired Cambridge UK software firm Ellexus for an undisclosed sum.Michigan-headquartered Altair is a global technology company providing solutions in data analytics, product...
View ArticleJapanese tech company joins GeoSpock’s new $5.4m round
Cambridge based extreme data analyser GeoSpock has taken its funding to date to $32 million following a new $5.4m round which underpins further global expansion for the business.GeoSpock, which has...
View ArticleNu Quantum £2.1m raise triggers fresh growth surge
A new state-of-the-art lab, a major recruitment drive and further R & D for quantum photonics technologies have been triggered by a £2.1 million seed funding round by Cambridge University spin-out...
View ArticleMarshall signs option for new home at Cranfield but defers Cambridge exit...
Marshall of Cambridge has signed a long-term option on land at Cranfield University’s massive site in the event of moving its Aerospace and Defence business there.But the company insists it does not...
View ArticleAbzena pumps $60m into new California manufacturing hub
Cash rich Cambridge UK life science business Abzena has invested $60 million into a new manufacturing nervecentre at its site in San Diego in the US. The move has already created 125 additional...
View ArticleUS government pays $1/2bn for AstraZeneca COVID-19 antibodies
The US government is laying out around $1/2 billion in new funding for a rapidly advanced antibody drug combination from Cambridge UK Big Bio business AstraZeneca.This deal for AstraZeneca’s COVID-19...
View ArticleCambridge quartet chosen for elite AI programme
Four Cambridge companies have been hand-picked for an elite UK programme designed to propel scaleups in the Artificial Intelligence sector to potential unicorn status accorded to private companies...
View ArticleExecution of deals in the COVID era
For the most part, a legal interest in land can only be transferred or created by deed. A deed must be in writing, and to be validly executed by an individual, they must sign in the presence of a...
View ArticleRethinking the future of the workforce
As the economy looks to reopen and the Government’s updated support packages come into force, business leaders are rethinking the future of their workforce, writes Gary Hanson, Audit Partner at BDO...
View ArticleCash through COVID
The COVID pandemic has highlighted the importance of access to finance for businesses and how relying solely on working capital inflows may not be enough in trickier trading times.To their credit, the...
View ArticleFormer White House climate change adviser becomes chair at Cambridge...
A former board member of one of the world’s biggest companies and White House climate change adviser has become chair of Xampla – a Cambridge University spin-out making plastic from peas. As...
View ArticleUS IPOs could surge as election looms
Adrian Bennett, a Partner in the Assurance team at EY in the East of England, comments on how regional life sciences businesses are becoming increasingly attractive propositions for global investors....
View ArticleAbcam raises $180m through US IPO
Cambridge-based Abcam, which supplies tools globally for life science research, has had a blockbusting response to its IPO on America’s NASDAQ technology exchange.It initially realised $156.5 million...
View ArticleAstraZeneca coronavirus trials resumed globally as FDA confirms safety
Clinical trials for the AstraZeneca-Oxford University coronavirus vaccine AZD1222 have today have been approved as safe to continue in the US by The Food and Drug Administration (FDA).The FDA reviewed...
View ArticleHauser seeks €100bn EU cash to fight US and China bid for tech dominance
Cambridge entrepreneur and VC Dr Hermann Hauser is mobilising forces in the EU to create a €100 billion fighting fund to protect European life science and hi-tech businesses from being lured to the US...
View ArticleEagle swoops on $9m scale-up funding
Cambridge-based Eagle Genomics, a pioneer in applying network science to biology – particularly linked to the microbiome – has closed $9 million in new scale-up funding. The UK technology business will...
View Article